Handok Inc.

teneligliptin

clinicaltrials.gov

NCT07102719

Phase 1Completed202540 people5 Aug 2025clinicaltrials.gov

NCT06889350

Phase 1Completed202540 people21 Mar 2025clinicaltrials.gov

NCT06339788

Phase 1Completed202440 people1 Apr 2024clinicaltrials.gov

Clinical Efficacy and Safety Evaluation of Teneligliptin in Type 2 Diabetes Who Have Inadequate GlycemIc Control With Empaglyflozin 25 mg and Metformin

Phase 3Completed2022214 people17 Aug 2022clinicaltrials.gov

NCT04431141

Phase 1Completed202032 people16 Jun 2020clinicaltrials.gov

NCT03787043

Phase 1Completed201430 people26 Dec 2018clinicaltrials.gov

NCT03787017

Phase 1Completed201436 people26 Dec 2018clinicaltrials.gov

NCT03769870

Phase 1Completed201930 people10 Dec 2018clinicaltrials.gov

NCT02512523

Phase 4Completed201539 people31 Jul 2015clinicaltrials.gov

NCT02175056

Phase 1Completed201458 people26 Jun 2014clinicaltrials.gov

NCT01444248

Phase 4Completed2010168 people30 Sept 2011clinicaltrials.gov

NCT00975065

Phase 4Completed2009266 people11 Sept 2009clinicaltrials.gov

NCT00934817

Phase 1Completed200736 people8 Jul 2009clinicaltrials.gov

NCT00934323

Phase 1Completed200833 people8 Jul 2009clinicaltrials.gov

NCT00913367

Phase 4Completed2009110 people4 Jun 2009clinicaltrials.gov

NCT00612144

Phase 4Completed2007192 people11 Feb 2008clinicaltrials.gov

NCT00437554

Phase 3Completed2006188 people21 Feb 2007clinicaltrials.gov